Ofatumumab in combination with glucocorticoids for primary therapy of chronic graft-versus-host disease: phase I trial results.
about
Emerging drugs for graft-versus-host disease.Mechanistic approaches for the prevention and treatment of chronic GVHD.Novel targets in the treatment of chronic graft-versus-host disease.Bronchiolitis obliterans syndrome in adults after allogeneic stem cell transplantation-pathophysiology, diagnostics and treatment.New and emerging therapies for acute and chronic graft versus host disease.The Role of B Cell Targeting in Chronic Graft-Versus-Host Disease.
P2860
Ofatumumab in combination with glucocorticoids for primary therapy of chronic graft-versus-host disease: phase I trial results.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Ofatumumab in combination with ...... isease: phase I trial results.
@en
type
label
Ofatumumab in combination with ...... isease: phase I trial results.
@en
prefLabel
Ofatumumab in combination with ...... isease: phase I trial results.
@en
P2093
P2860
P1476
Ofatumumab in combination with ...... isease: phase I trial results.
@en
P2093
Asmita Mishra
Claudio Anasetti
Ernesto Ayala
Hugo F Fernandez
Jongphil Kim
Joseph Pidala
Leonel Ochoa-Bayona
Marcie Riches
Melissa Alsina
P2860
P304
P356
10.1016/J.BBMT.2015.03.014
P577
2015-03-21T00:00:00Z